Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Sven Plum

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|November 15, 2023
Pan-cancer analysis and <i>in vitro</i> validation of the oncogenic and prognostic roles of <i>AURKA</i> in human cancersChuang Yang, Patrick Sven Plum, Ines Gockel, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 3, 2020
[Surgical treatment of esophageal cancer-Indicators for quality in diagnostics and treatment]Jens Hoeppner, Patrick Sven Plum, Heinz Buhr, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 28, 2022
Outcome of prophylactic endoscopic vacuum therapy for high-risk anastomosis after esophagectomySeung-Hun Chon, Felix Berlth, Thomas Dratsch, et al.
Surgical Endoscopy|October 9, 2019
Efficacy and feasibility of OverStitch suturing of leaks in the upper gastrointestinal tractSeung-Hun Chon, Ulrich Toex, Patrick Sven Plum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative ChemoradiotherapyJens Hoeppner, Claudia Schmoor, Thomas Brunner, et al.
Zentralblatt Fur Chirurgie|April 8, 2025
[Innovations in the Current Guideline on Gastric Carcinoma and Outlook for the Future]Robert Nowotny, Philipp Rhode, Stefan Niebisch, et al.
Cancer Medicine|May 23, 2024
Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomachElfriede Bollschweiler, Arnulf H Hölscher, Sheraz R Markar, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinomaAlexander Damanakis, Patrick Sven Plum, Florian Gebauer, et al.
Surgical Endoscopy|March 15, 2018
Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparisonPatrick Sven Plum, Arnulf Heinrich Hölscher, Kristin Pacheco Godoy, et al.
Zentralblatt Fur Chirurgie|August 8, 2025
[Functional Outcome of Radiotherapy, Chemotherapy and Surgery in the Treatment of Rectal Cancer]Philipp Rhode, Matthias Mehdorn, Undine Gabriele Lange, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|November 15, 2023
Pan-cancer analysis and <i>in vitro</i> validation of the oncogenic and prognostic roles of <i>AURKA</i> in human cancersChuang Yang, Patrick Sven Plum, Ines Gockel, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 3, 2020
[Surgical treatment of esophageal cancer-Indicators for quality in diagnostics and treatment]Jens Hoeppner, Patrick Sven Plum, Heinz Buhr, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 28, 2022
Outcome of prophylactic endoscopic vacuum therapy for high-risk anastomosis after esophagectomySeung-Hun Chon, Felix Berlth, Thomas Dratsch, et al.
Surgical Endoscopy|October 9, 2019
Efficacy and feasibility of OverStitch suturing of leaks in the upper gastrointestinal tractSeung-Hun Chon, Ulrich Toex, Patrick Sven Plum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative ChemoradiotherapyJens Hoeppner, Claudia Schmoor, Thomas Brunner, et al.
Zentralblatt Fur Chirurgie|April 8, 2025
[Innovations in the Current Guideline on Gastric Carcinoma and Outlook for the Future]Robert Nowotny, Philipp Rhode, Stefan Niebisch, et al.
Cancer Medicine|May 23, 2024
Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomachElfriede Bollschweiler, Arnulf H Hölscher, Sheraz R Markar, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinomaAlexander Damanakis, Patrick Sven Plum, Florian Gebauer, et al.
Surgical Endoscopy|March 15, 2018
Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparisonPatrick Sven Plum, Arnulf Heinrich Hölscher, Kristin Pacheco Godoy, et al.
Zentralblatt Fur Chirurgie|August 8, 2025
[Functional Outcome of Radiotherapy, Chemotherapy and Surgery in the Treatment of Rectal Cancer]Philipp Rhode, Matthias Mehdorn, Undine Gabriele Lange, et al.
Pageof 4